更正：在苏丹耐多药结核病中采用靶向最大似然估计来评估先前结核病治疗的因果效应。
Correction: The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.
作者信息
Elduma Adel Hussein, Holakouie-Naieni Kourosh, Almasi-Hashiani Amir, Foroushani Abbas Rahimi, Ali Hamdan Mustafa Hamdan, Adam Muatsim Ahmed Mohammed, Elsony Asma, Mansournia Mohammad Ali
出版信息
PLoS One. 2024 Dec 2;19(12):e0314954. doi: 10.1371/journal.pone.0314954. eCollection 2024.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0279976.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0279976。]
相似文献
1
Correction: The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.更正：在苏丹耐多药结核病中采用靶向最大似然估计来评估先前结核病治疗的因果效应。
PLoS One. 2024 Dec 2;19(12):e0314954. doi: 10.1371/journal.pone.0314954. eCollection 2024.
2
The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.针对苏丹耐多药结核病患者，采用目标最大似然估计法估计既往结核病治疗的因果效应。
PLoS One. 2023 Jan 17;18(1):e0279976. doi: 10.1371/journal.pone.0279976. eCollection 2023.
3
Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis.利用靶向学习估计耐多药结核病治疗的重要性：一项观察性个体患者数据网络荟萃分析。
Biometrics. 2020 Sep;76(3):1007-1016. doi: 10.1111/biom.13210. Epub 2020 Jan 7.
4
Prevalence of and risk factors for multidrug-resistant tuberculosis in Iran and its neighboring countries: systematic review and meta-analysis.伊朗及其邻国耐多药结核病的患病率和危险因素：系统评价与荟萃分析
Rev Soc Bras Med Trop. 2017 May-Jun;50(3):287-295. doi: 10.1590/0037-8682-0002-2017.
5
Survival Probability in Multidrug Resistant Pulmonary Tuberculosis Patients in a South Indian Region.印度南部地区耐多药肺结核患者的生存概率
Hosp Pharm. 2024 Aug;59(4):427-435. doi: 10.1177/00185787231224065. Epub 2024 Apr 23.
6
Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.埃塞俄比亚环境下的耐多药结核病及其与既往抗结核治疗史的关联：一项系统评价与荟萃分析
BMC Infect Dis. 2017 Mar 20;17(1):219. doi: 10.1186/s12879-017-2323-y.
7
Treatment outcomes in cavitary multidrug-resistant/rifampicin-resistant tuberculosis and risk factors for cavity closure: a retrospective cohort study in Southwest China.空洞型耐多药/利福平耐药结核病的治疗结局及空洞闭合的危险因素：中国西南地区的一项回顾性队列研究
Sci Rep. 2025 Jul 1;15(1):21302. doi: 10.1038/s41598-025-06080-z.
8
Evaluation of the role of and in the dominant multidrug-resistant clone B0/W148.评估 和 在优势多重耐药克隆B0/W148中的作用。 （你提供的原文中“ 和 ”这里表述不完整，可能存在信息缺失）
Microbiol Spectr. 2025 Jul;13(7):e0322424. doi: 10.1128/spectrum.03224-24. Epub 2025 May 22.
9
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis.一线药物治疗耐异烟肼结核病：系统评价和荟萃分析。
Lancet Infect Dis. 2017 Feb;17(2):223-234. doi: 10.1016/S1473-3099(16)30407-8. Epub 2016 Nov 17.
10
Comprehensive evaluation of the MeltPro MTB/PZA assay for prediction of pyrazinamide resistance in multidrug-resistant tuberculosis.MeltPro MTB/PZA检测法对耐多药结核病中吡嗪酰胺耐药性预测的综合评估
Microbiol Spectr. 2025 Jul;13(7):e0274524. doi: 10.1128/spectrum.02745-24. Epub 2025 May 22.
本文引用的文献
1
The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.针对苏丹耐多药结核病患者，采用目标最大似然估计法估计既往结核病治疗的因果效应。
PLoS One. 2023 Jan 17;18(1):e0279976. doi: 10.1371/journal.pone.0279976. eCollection 2023.
Zotero 插件